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a single-nucleotide polymorphism (rs738409; C>G/I148M) in the patatin-like phospholipase domain containing 3 ( PNPLA3 , adiponutrin) gene, to be strongly associated with NAFLD. A meta-analysis of 16 studies demonstrated that homozygous carriers of PNPLA3 I148M have on the average a 73% higher liver fat content than weight-matched homozygous carriers of the major allele ( 5 ) . However, NAFLD associated with PNPLA3 I148M is distinct from obesity-associated common NAFLD, as it is not characterized by features of the metabolic syndrome such as hyperinsulinemia or dyslipidemia ( 1, 5 ) .
In vitro assays using recombinant PNPLA3 have suggested that the WT PNPLA3 (PNPLA3 WT ) hydrolyzes emulsifi ed triacylglycerol (TAG) and that the I148M substitution in PNPLA3 (PNPLA3 I148M ) abolishes this activity (6) (7) (8) . Moreover, the protein was shown to display a transacylase activity ( 7 ) , and to prefer oleic acid (18:1n-9) as the fatty acyl moiety ( 9 ) . Opposing a putative role as a lipase, PNPLA3 is induced by glucose and insulin (10) (11) (12) and is a target gene of the lipogenic transcription factors SREBP-1c and the carbohydrate responsive element binding protein, ChREBP (13) (14) (15) (16) . Kumari et al. ( 17 ) suggested that the protein acts as lipogenic lysophosphatidic acid (LPA) acyltransferase, converting LPA to phosphatidic acid (PA), and that the I148M substitution increases this activity. Because PA acts as a precursor for both phospholipids and TAGs, this provided an alternative explanation for the hepatic fat accumulation in the PNPLA3 I148M allele carriers. Even though PNPLA3 knockout mice have no metabolic phenotype ( 18, 19 ) , Kumashiro et al. ( 20 ) reported that reducing PNPLA3 in rat liver via RNA interference prevented hepatic steatosis, an effect attributed to 
PNPLA3
I148M localized more extensively to lipid droplets (LDs) than PNPLA3 ice-cold 0.25 M sucrose. An aliquot of 100 l was withdrawn for total cell protein analysis using the BCA assay (Thermo Fisher Scientifi c, Waltham, MA). The data for glycerolipid synthesis represents seven parallel cell cultures originating from two independent labeling experiments [the TAG and phosphatidylcholine (PC) species profi les in both experiments were in general the same and are shown in detail for the fi rst experiment, supplementary Tables I, II] .
For analysis of TAG hydrolysis, the cells were cultured on 6 cm dishes and transfected as described above, washed, and changed into growth medium supplemented with 5% delipidated FBS and 5 M triacsin C (Enzo Life Sciences, Farmingdale, NY). After 0, 6, or 24 h chase times in this medium, the cells were washed with PBS and scraped into 1 ml of ice-cold 0.25 M sucrose.
For analysis of TAG turnover, HuH7 cells in complete growth medium without antibiotics were transfected for 24 h as above and then labeled for 24, 48, or 72 h with 15 g/ml [D17]18:1n-9 (71-1851; Larodan Fine Chemicals, Malmö, Sweden) using fatfree BSA as a vehicle. The lipids were extracted, and the unlabeled and labeled TAG species detected by MS as detailed below.
Lipid extraction, MS, and GC of FAs
Cellular lipids were extracted according to Folch et al. ( 25 ) and dissolved in chloroform:methanol 1:2. Immediately before MS, 1% NH 4 OH was added along with an internal standard mixture containing polar and neutral lipid species. The samples were infused into an ion trap ESI mass spectrometer (Esquire-LC, Bruker-Franzen Analytik, Bremen, Germany) and spectra recorded by employing both positive and negative ionization mode in the range of m / z 500-1,000 ( 26 ) . The unlabeled [M] and [ 13 C]glycerol-labeled [M+3] ions were resolved by comparing the spectra of cell samples with or without labeling, and deconvolution into different peaks was performed by the best profi le fi tting available in LIMSA software ( 27 ) . In addition, FA composition of total lipids was determined by GC as detailed in Käkelä et al. ( 28 ) . In order to confi rm glycerolipid species structures, the precursor scans for the main acyl chains detected by GC were later recorded in ESI-MS/ MS experiments for TAGs (positive mode neutral loss scans for the FAs) and PCs (negative mode precursor scans for the FAs of PC formate adducts) using a triple quadrupole mass spectrometer (Agilent 6490 Triple Quad LC/MS with iFunnel Technology; Agilent Technologies, Santa Clara, CA). The [D17]18:1n-9 incorporation into TAG and the following turnover were studied using the triple quadrupole equipment by scanning for the positive mode neutral loss of the unlabeled and deuterated 18:1n-9 moiety .
For analysis of DAGs and PAs by ion trap ESI-MS, cellular lipids were extracted using a modifi ed Bligh/Dyer procedure ( 29 ) . First, 800 l of ice-cold 0.1 N HCl:methanol (1:1) was added to each cell pellet and DAG 24:0 was inserted as an internal standard. Then 400 l of ice-cold chloroform was added and the separated lower phase was collected, evaporated to dryness under nitrogen fl ow, and fi nally the original volume was restored by adding chloroform: methanol (1:9). The mass spectra for the DAG species were recorded in the positive ionization mode over the range of m / z 400-750. The spectra for PA species were recorded over the range of m / z 600-800 by using samples brought into chloroform:methanol (1:2) and using PA 34:0 as internal standard.
The ion trap ESI-MS spectra were processed by Bruker Daltonics (Billerica, MA) data analysis software and the triple quadrupole ESI-MS/MS spectra by Agilent Mass Hunter software. Individual lipid species were quantifi ed by using the internal standards and the LIMSA software ( 27 ) .
Fluorescence microscopy
To analyze the subcellular distribution of PNPLA3, HuH7 cells were transfected for 48 h with plasmids encoding GFP-PNPLA3 WT decreased FA esterifi cation. In apparent contradiction with these fi ndings, the study by Pirazzi et al. ( 21 ) in human subjects showed a reduced rate of large TAG-rich VLDL secretion in I148M carriers versus 148II homozygotes for any amount of liver fat, suggesting that PNPLA3 I148M represents a loss-of-function mutant that promotes hepatocyte TAG accumulation via reduction of VLDL assembly, putatively by inhibiting the mobilization of TAG FAs. Li et al. ( 22 ) recently developed transgenic mice overexpressing WT human PNPLA3 or the I148M variant either in liver or adipose tissue. Expression of PNPLA3 I148M , but not the WT protein, in the liver recapitulated the fatty liver phenotype. The abovementioned metabolic studies suggested that the increase in hepatic TAGs associated with the I148M allele results from multiple changes in hepatic TAG metabolism. Both PNPLA3 WT and PNPLA3 I148M localize prominently on cytoplasmic lipid droplets (LDs) ( 6, 23 ) . Thus, the mechanism by which PNPLA3 I148M causes NAFLD is still controversial.
In the present study, we examined the mechanisms by which PNPLA3 and its I148M variant modify the lipid content and composition of human hepatic cells in vitro. We acutely overexpressed PNPLA3 WT or PNPLA3 I148M in the HuH7 hepatoma cell line, which expresses no detectable endogenous PNPLA3, cultured the cells under stable isotope labeling of TAGs with [ 13 C]glycerol, and performed turnover experiments with oleic acid (18:1n-9) labeled with 17 deuterium atoms ([D17]18:1n-9). Cellular TAGs, diacylglycerols (DAGs), and phospholipids were examined by MS. Further evidence of the functional difference between PNPLA3 WT and PNPLA3 I148M was obtained by comparing their subcellular distributions in the presence or absence of FA supplementation.
MATERIALS AND METHODS

Cell culture
HuH7 cells ( 24 ) were grown in MEM (GIBCO/Life Technologies, Carlsbad, CA), containing 10% FBS, 2 mM L -glutamine, 100 U/ml penicillin, and 100 g/ml streptomycin.
cDNA constructs and antibodies
The PNPLA3 cDNA open-reading frame corresponding to NM_025225 was isolated by PCR from human subcutaneous adipose tissue and inserted into the Eco RI site of pcDNA4HisMaxC (Invitrogen/Life Technologies) and pEGFP-C2 (Clontech/Takara Bio, Mountain View, CA). The I148M substitution corresponding to the rs738409 G allele was introduced in the PNPLA3 cDNA with the Quikchange site-directed mutagenesis kit (Stratagene, La Jolla, CA). Rabbit anti-PNPLA3, anti-␤ -actin (Sigma-Aldrich, St. Louis, MO), and anti-green fl uorescent protein (GFP) (Life Technologies, Grand Island, NY) were employed for detection of Western blots.
PNPLA3 overexpression and treatments of cells
For analysis of preexisting and newly synthesized glycerolipids, HuH7 cells cultured on 6-well plates were transfected with an empty vector, PNPLA3 WT , or PNPLA3 I148M -pcDNAHisMaxC using Lipofectamine 2000 TM (Invitrogen). One day after transfection medium was changed to a labeling medium containing 500 g/ml of [ of 53 kDa) detectable by Western blot analysis ( Fig. 1A ). After 24 h of transfection, the cells were subjected to 24 h metabolic labeling of glycerolipids with [ 13 C]glycerol, and the cellular lipids were thereafter analyzed by MS. After the [ 13 C]glycerol labeling (total transfection time of 48 h), the cells expressing PNPLA3 I148M displayed a marked net increase of unlabeled TAGs compared with mocktransfected controls, while expression of PNPLA3 WT had no such effect ( Fig. 1B ) . While the unlabeled TAGs represent lipids that were present in the cells already before the labeling, the [ 13 C]TAGs represent the newly synthesized species. After 48 h of transfection, the concentrations of [ 13 C] TAGs were similar in controls and cells expressing either form of PNPLA3 ( Fig. 1C ), suggesting that PNPLA3 does not primarily enhance de novo TAG synthesis. Consistent with earlier fi ndings ( 6, 15 ) , when the cells were incubated for 6 or 24 h in a medium supplemented with 5% delipidated serum and the long chain FA-CoA synthase inhibitor Triacsin C, PNPLA3 I148M caused a kinetic delay in TAG hydrolysis (data not shown). Thus, PNPLA3 I148M expression results in net TAG accumulation in the absence of altered synthesis of TAGs, but with a delay in their hydrolysis.
PNPLA3 induces redistribution of FAs between TAGs and membrane phospholipids
To analyze in detail the effect of PNPLA3 on the hepatocellular glycerolipid dynamics, we studied the lipid species profi les of the [ 13 C]glycerol-labeled cells (values for the glycerolipid species from the experiment described in Tables I-IV) . According to PCA, the TAG profi les of both PNPLA3 WT and PNPLA3 I148M cells were found to differ signifi cantly from those of the controls ( Fig. 2A ) . The most important principal component extracted (PC1) explained 35% of the TAG variation between the constructs and refl ected the degree of FA unsaturation. Cells expressing either form of PNPLA3 were characterized by increased relative amounts of TAGs with saturated FA (SFA) and MUFA moieties. The WT and I148M cells differed with respect to principal or GFP-PNPLA3 I148M by using Lipofectamine 2000. Prior to fi xation with 4% paraformaldehyde, cells were treated for indicated times with 200 M oleic acid-BSA as described ( 30 ) . For LD visualization, cells were stained immediately after fi xation with LipidTox Red (Invitrogen/Life Technologies) according to the manufacturer's instructions and imaged with a TCS SP2 confocal microscope (Leica, Wetzlar, Germany). The percentage of cells exhibiting predominantly reticular/cytosolic PNPLA3 distribution was determined by visual inspection of cells from 10 randomly selected fi elds under a wide-fi eld AX70 microscope (Olympus, Hamburg, Germany).
Statistical analysis of lipid levels
For univariate comparisons of the cellular lipid levels, statistical signifi cance for the differences between control, PNPLA3 WT , and PNPLA3 I148M overexpressing samples were assessed by using one-way ANOVA followed by Newman-Keuls test of means (SPSS Statistics, IBM, North Castle, NY). For multivariate comparisons of detailed lipid profi les, principal component analysis (PCA) (Sirius, PRS, Bergen, Norway) was used. The PCA describes compositional differences between the samples, and highlights the lipid species mainly responsible for the variation in the data. PCA was computed using arcsine transformed data and the relative positions of the samples and variables were plotted using the fi rst two principal components. In addition, quantitative multivariate measures of the compositional differences among the sample groups were determined by soft independent modeling of class analogy (SIMCA; Sirius) ( 31 ) . To analyze the rate of TAG remodeling, regression lines of groups were compared by measuring the effect of a categorical factor on the responding variable, by using the 'aov' function in the 'stats' package of R. The statistical differences in the proportion of cells where PNPLA3 was present in cytosol or endoplasmic reticulum (ER) were tested by Student's t -test.
RESULTS
PNPLA3 I148M induces net TAG accumulation
We acutely overexpressed PNPLA3 WT or PNPLA3 I148M in the hepatoma cell line HuH7, which contains no endogenous PNPLA3 protein (with an apparent molecular mass Supplemental Material can be found at: not shown). When applied for DAG species, the PCA followed by SIMCA ( P < 0.05) showed that the profi le of PNPLA3 I148M -expressing cells was signifi cantly different from those of the controls and the PNPLA3 WT cells: the I148M cells were enriched with species containing SFAs or MUFAs. PNPLA3 WT cells localized in the PCA between the PNPLA3 I148M and control cells, and did not differ in SIMCA from the latter ( Fig. 2B ) . The total cellular DAG content was unaffected by PNPLA3 WT /PNPLA3 I148M expression. Analysis of the species profi les of cellular PCs, the major membrane phospholipid class of mammalian hepatocytes, showed a signifi cant shift (SIMCA, P < 0.05) toward species carrying PUFAs in both PNPLA3 WT -and PNPLA3 I148M transfected cells, especially arachidonic acid (20:4n-6) (e.g., Fig. 2A ) and less of their unlabeled counterparts than the I148M cells (low on PC2 axis). This observation is consistent with a more active remodeling of these TAGs in cells expressing the PNPLA3 WT as compared with the PNPLA3 I148M cells. The differences between the cells (control, WT, and I148M) seen on the PCA biplot were studied quantitatively by the SIMCA method, which confi rmed that the TAG profi les of the three transfected cell pools signifi cantly differed from each other ( P < 0.05, test graphics diffuse cytosolic/ER distribution being detectable only in 24% of the cells ( Fig. 4A, B ) . Loading of the cells for 24 h with 18:1n-9 to enhance TAG synthesis resulted in an increase of the LD association of both PNPLA3 WT and PNPLA3 I148M ( Fig. 4A, B ), suggesting that the lipid content and/or metabolic status of the LDs modulates PNPLA3 association with these organelles. Of note, Western analysis of the cells verifi ed that both the GFP-PNPLA3 WT and the GFP-PNPLA3 I148M fusion proteins remained intact and were expressed at similar levels ( Fig. 4C ).
DISCUSSION
The mechanism of PNPLA3 function and the reasons for hepatic TAG accumulation in carriers of the I148M allele are the subject of vivid debate. While PNPLA3 has been suggested to act either as a TAG lipase ( 6, 21 ) or as a lipogenic LPA acyltransferase ( 17 ) , the present study employing a cultured human hepatocyte model provides evidence for a more complex mode of PNPLA3 action in hepatocyte TAG remodeling, an activity that is partially inhibited in the I148M variant. The key observations supporting this interpretation are: i ) PNPLA3 WT overexpression causes no signifi cant net reduction of cellular TAGs; ii ) PNPLA3 I148M induces net accumulation of TAGs and slows down TAG hydrolysis upon cellular lipid depletion ( 6, 15 ) ; iii ) Both PNPLA3 WT and PNPLA3 I148M induce cellular enrichment of SFA-and MUFA-containing TAGs, and simultaneously enrichment of PCs with PUFAs; iv ) Upon [ 13 C] glycerol labeling, PNPLA3 WT is associated with cellular enrichment of newly synthesized [ 13 C]TAG species having 52 or 50 acyl carbons and carrying one or several 18:1n-9 FAs, whereas PNPLA3 I148M associates with the corresponding unlabeled TAGs; v ) Upon [D17]18:1n-9 labeling in 36:4, 38:5, and 38:4), while the total cellular PC content did not differ signifi cantly between the control and PNPLA3 WT / PNPLA3 I148M -transfected cells ( Fig. 2C ) . Regarding the composition of PC species, cells transfected with either of the PNPLA3 constructs differed signifi cantly (SIMCA, P < 0.05) from the controls, and the PNPLA3 WT induced a more pronounced shift in the PC species composition than PNPLA3 I148M ( Fig. 2C ). This result, in the face of TAGs enriched with SFAs and MUFAs, suggests net transfer of PUFAs from TAGs to membrane phospholipids by the protein. The same phenomenon was seen in two independent experiments (data of the repeat experiment not shown). In extended cultures beyond 72 h, the FA composition of the PNPLA3 I148M -expressing cells was also slightly altered. The relative amounts of MUFAs 18:1n-7 and 16:1n-7 (vaccenic and palmitoleic acids, respectively) were signifi cantly increased as compared with the controls or PNPLA3 WT transfected cells (ANOVA, P < 0.05; supplementary Table V) .
PNPLA3 overexpression has no impact on hepatocellular PAs
Prompted by the report of Kumari et al. ( 17 ) suggesting that PNPLA3 displays LPA acyltransferase activity, we analyzed the PA contents and species profi les in the transfected HuH7 cells. The PA patterns of PNPLA3 WT / PNPLA3 I148M -expressing cells or the total cellular amount of PAs did not differ signifi cantly from the controls ( Fig. 2D ).
PNPLA3 WT , but not PNPLA3
I148M , enhances the remodeling of TAGs
To directly assess the possibility that PNPLA3 facilitates the remodeling of hepatocyte TAGs, we carried out labeling of transfected HuH7 cells in serum containing growth medium with stable isotope [D17]18:1n-9, the preferred substrate of PNPLA3 ( 9 ), for 24, 48, or 72 h, followed by lipid extraction and mass spectrometric analysis of the TAGs. At the 24 h time point, analysis of the relative amount of [D17]-labeled versus unlabeled 18:1-containing TAGs revealed a signifi cant increase of [D17]18:1n-9 incorporation into TAGs in cells expressing PNPLA3 WT , an effect not observed with PNPLA3 I148M ( Fig. 3 ). After this time point, the relative amount of [D17] TAGs reduced in PNPLA3 WT -expressing cells more rapidly as compared with PNPLA3 I148 or the mock-transfected control ( P < 0.01), all three groups of transfected cells ending up at the same level at the 72 h time point ( Fig. 3 ) . These observations suggest that PNPLA3 WT enhances both 18:1n-9 incorporation into TAGs and its removal from these lipids, a remodeling activity defective in PNPLA3 I148M .
PNPLA3 I148M localizes more extensively to LDs than the WT protein
To assess the subcellular distribution and the putative impact of PNPLA3 on LD morphology, we expressed the GFP-tagged WT or I148M proteins in HuH7 cells, followed by LD visualization with the LipidTox Red dye ( Fig. 4 ) . In most cells PNPLA3 associated with LDs, but 46% of the cells exhibited, in addition, a more diffuse pattern, most likely refl ecting cytosolic and ER distribution. Interestingly, PNPLA3 I148M associated more faithfully with LDs, a , enhances the hepatocellular remodeling of TAGs. HuH7 cells transfected with empty vector (Ctrl) or the indicated PNPLA3 expression constructs were labeled in complete growth medium with [D17]18:1n-9 as specifi ed in the Materials and Methods, followed by lipid extraction and mass spectrometric quantifi cation of TAG molecular species. The data represent the amount of [D17]18:1n-9-containing TAGs relative to the corresponding unlabeled species, a ratio which decreased rapidly for the PNPLA3 WT cells. The data points represent mean ± SD, n = 4-5, and the P value indicates signifi cant difference between the regression models. complete growth medium, PNPLA3 WT , but not PNPLA3 I148M , enhances the incorporation of this deuterated FA into TAGs during 24 h and speeds up its turnover during longer labeling times. Thus, even though PNPLA3 WT does not signifi cantly affect the total cellular TAG content, it has a distinct impact on the incorporation and removal of its preferred substrate fatty acyl moiety, 18:1n-9 ( 9 ), into/ from TAGs, an activity defective in PNPLA3 I148M .
The facts that the PNPLA3-induced alterations in molecular species composition observed in TAGs, DAGs, and PCs were not present in PAs, and that the total cellular PA content was not signifi cantly altered, suggest that PNPLA3 may not signifi cantly modify lipid syntheses at the level of PA ( 17 ) . However, unaltered PA steady state concentrations do not rule out dynamic changes of PA metabolism. In earlier work with the same hepatic cell model, we found no signifi cant effect of PNPLA3 WT or PNPLA3 I148M on de novo lipogenesis as measured by [ 3 H]acetate labeling ( 15 ) .
Acyl chain remodeling is considered a frequent process in hepatocytes, and in addition to acyltransferases, transacylases are present that catalyze the acyl chain transfer ( 32, 33 ) . Our cell model data employing acute overexpression of PNPLA3 reveals that PNPLA3 has the capacity to modify the TAG, DAG, and PC FA composition. This could involve hydrolysis of TAG FA ester bonds, followed by activation of the released FAs by CoA and transfer to the FA scavenging acceptor lyso-PC to form PC ( 34 ) or to DAGs to resynthesize TAGs. Alternatively, PNPLA3 may catalyze or facilitate CoAindependent direct FA transfer between lipids, designated transacylase activity ( 7 ) . PNPLA3 has been shown to display both TAG lipase and transacylase activities in vitro (6) (7) (8) . The present data are compatible with TAG remodeling via either of these routes. The observed enrichment of cellular TAGs with SFA-and MUFA-containing species suggests that the PNPLA3-associated remodeling activity exhibits FA selectivity. However, PNPLA3 displays no fatty acyl-CoA DAG acyltransferase activity in vitro, suggesting that PNPLA3 does not directly mediate FA reesterifi cation into TAGs ( 9 ) . Instead, the transacylation activity assigned for PNPLA3 ( 7 ) may target selected FAs. The fact that PNPLA3 I148M associated in [ 13 C]glycerol labeling experiments with the preexisting unlabeled 52:1 and 50:1 TAGs and the WT protein with the corresponding newly synthesized species, the retardation of TAG hydrolysis by PNPLA3 I148M , as well as the lack of effect by PNPLA3 I148M on [D17]18:1n-9 labeling of TAGs and turnover of the label, suggested that a hallmark property of the NAFLD-associated PNPLA3 I148M is a defect in TAG remodeling. Because each cycle of FA ester hydrolysis and reesterifi cation results in a "leak" of FAs for oxidation, phospholipid synthesis, or VLDL assembly ( 32 ) , such a defect may eventually result in net TAG accumulation. In chronic long-term accumulation of large LDs rich in hydrophobic TAG species, the mobilization rate of TAG is further decelerated ( 35 ) . Thus, altered TAG remodeling in cells expressing PNPLA3 I148M may generate LDs with a TAG composition resistant to hydrolysis. This interpretation is compatible with the complex phenotypic effects of human PNPLA3 I148M expressed in the liver of transgenic mice ( 22 ) and the published human data ( 21 ) . PNPLA3 was recently shown to localize to LDs in both hepatocytes ( 6 ) and fi broblast-like cells ( 23 ) . Our morphologic observations in hepatic cells suggest that PNPLA3 I148M associates more extensively with LD surfaces than PNPLA3 WT . Moreover, FA loading of the hepatoma cells enhanced the association of both PNPLA3 WT and PNPLA3 I148M with the enlarged LDs. While the effect of PNPLA3 I148M on hepatocyte LD size has been established ( 6, 22, 23 ) , its increased association with LDs is a novel observation. It is possible that upon FA loading, the increase in LD size, and in the amount of stored TAG are suffi cient to enhance PNPLA3 association with the LDs, and that this effect is more pronounced with PNPLA3 I148M which facilitates net TAG accumulation. On the other hand, the more extensive LD localization of PNPLA3 I148M may refl ect its altered function in TAG metabolism. It could, for instance, modify the recruitment of cofactors regulating lipase or FA reesterifi cation activity on the LD surface ( 23 ) .
PNPLA3 transcription is, similarly to a number of lipogenic genes, induced by refeeding glucose and insulin (10) (11) (12) , consistent with the notion that its function is not predominantly lipolytic. If PNPLA3 acts to control cycles of TAG remodeling, what would be the physiologic role of this activity? We fi nd it possible that, under conditions of insulin-induced lipogenesis, increased levels of PNPLA3 are needed to maintain the dynamic metabolic properties of the rapidly growing LDs and selective sorting of FAs between the pools of storage and membrane lipids.
As a conclusion, our data suggests that PNPLA3 facilitates hepatic TAG remodeling in a FA-selective manner. The present fi ndings are consistent with a model in which PNPLA3 I148M induces a defect in TAG remodeling, resulting in hepatocellular TAG accumulation.
